These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 17637189)
1. Induction of P-glycoprotein expression and activity by ritonavir in bovine brain microvessel endothelial cells. Perloff MD; von Moltke LL; Fahey JM; Greenblatt DJ J Pharm Pharmacol; 2007 Jul; 59(7):947-53. PubMed ID: 17637189 [TBL] [Abstract][Full Text] [Related]
2. Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line. Zastre JA; Chan GN; Ronaldson PT; Ramaswamy M; Couraud PO; Romero IA; Weksler B; Bendayan M; Bendayan R J Neurosci Res; 2009 Mar; 87(4):1023-36. PubMed ID: 18855943 [TBL] [Abstract][Full Text] [Related]
3. Effects of various principles from Chinese herbal medicine on rhodamine123 accumulation in brain capillary endothelial cells. He L; Liu GQ Acta Pharmacol Sin; 2002 Jul; 23(7):591-6. PubMed ID: 12100750 [TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of HIV-1 protease inhibitor interactions with drug efflux transporters in the blood-brain barrier. Bachmeier CJ; Spitzenberger TJ; Elmquist WF; Miller DW Pharm Res; 2005 Aug; 22(8):1259-68. PubMed ID: 16078135 [TBL] [Abstract][Full Text] [Related]
6. Effect of E6, a novel calmodulin inhibitor, on activity of P-glycoprotein in purified primary cultured rat brain microvessel endothelial cells. Zhu HJ; Liu GQ Acta Pharmacol Sin; 2003 Nov; 24(11):1143-9. PubMed ID: 14627500 [TBL] [Abstract][Full Text] [Related]
7. Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein (MRP1) expression, and drug transporter-mediated activity in a human intestinal cell line. Perloff MD; Von Moltke LL; Marchand JE; Greenblatt DJ J Pharm Sci; 2001 Nov; 90(11):1829-37. PubMed ID: 11745741 [TBL] [Abstract][Full Text] [Related]
8. Atazanavir: effects on P-glycoprotein transport and CYP3A metabolism in vitro. Perloff ES; Duan SX; Skolnik PR; Greenblatt DJ; von Moltke LL Drug Metab Dispos; 2005 Jun; 33(6):764-70. PubMed ID: 15764714 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of P-glycoprotein function by procyanidine on blood-brain barrier. He L; Zhao C; Yan M; Zhang LY; Xia YZ Phytother Res; 2009 Jul; 23(7):933-7. PubMed ID: 19172664 [TBL] [Abstract][Full Text] [Related]
10. Functional expression of P-glycoprotein in rat brain microglia. Lee G; Schlichter L; Bendayan M; Bendayan R J Pharmacol Exp Ther; 2001 Oct; 299(1):204-12. PubMed ID: 11561081 [TBL] [Abstract][Full Text] [Related]
11. Modulation of P-glycoprotein in rat brain microvessel endothelial cells under oxygen glucose deprivation. Ji BS; Cen J; He L; Liu M; Liu YQ; Liu L J Pharm Pharmacol; 2013 Oct; 65(10):1508-17. PubMed ID: 24028618 [TBL] [Abstract][Full Text] [Related]
12. Stereoselective Regulation of P-gp Activity by Clausenamide Enantiomers in Caco-2, KB/KBv and Brain Microvessel Endothelial Cells. Zhu CJ; Hua F; Zhu XL; Li M; Wang HX; Yu XM; Li Y PLoS One; 2015; 10(8):e0135866. PubMed ID: 26295572 [TBL] [Abstract][Full Text] [Related]
13. Comparison of drug efflux transport kinetics in various blood-brain barrier models. Bachmeier CJ; Trickler WJ; Miller DW Drug Metab Dispos; 2006 Jun; 34(6):998-1003. PubMed ID: 16554372 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of P-glycoprotein activity at the primate blood-brain barrier increases the distribution of nelfinavir into the brain but not into the cerebrospinal fluid. Kaddoumi A; Choi SU; Kinman L; Whittington D; Tsai CC; Ho RJ; Anderson BD; Unadkat JD Drug Metab Dispos; 2007 Sep; 35(9):1459-62. PubMed ID: 17591677 [TBL] [Abstract][Full Text] [Related]
16. Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption. Miller DW; Batrakova EV; Waltner TO; Alakhov VYu ; Kabanov AV Bioconjug Chem; 1997; 8(5):649-57. PubMed ID: 9327127 [TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein and ritonavir: an interaction between antiretrovirals and lipids mediated by P-glycoprotein. Tempestilli M; Elisei F; Cimini E; D'Avolio A; Grassi G; Nicastri E; Narciso P; Martini F; Alonzi T; Paolo Pucillo L J Antimicrob Chemother; 2014 Jul; 69(7):1760-6. PubMed ID: 24648507 [TBL] [Abstract][Full Text] [Related]
18. The distribution of the HIV protease inhibitor, ritonavir, to the brain, cerebrospinal fluid, and choroid plexuses of the guinea pig. Anthonypillai C; Sanderson RN; Gibbs JE; Thomas SA J Pharmacol Exp Ther; 2004 Mar; 308(3):912-20. PubMed ID: 14634041 [TBL] [Abstract][Full Text] [Related]
19. Effect of protease inhibitor-containing regimens on lymphocyte multidrug resistance transporter expression. Ford J; Meaden ER; Hoggard PG; Dalton M; Newton P; Williams I; Khoo SH; Back DJ J Antimicrob Chemother; 2003 Sep; 52(3):354-8. PubMed ID: 12917239 [TBL] [Abstract][Full Text] [Related]
20. Polarized P-glycoprotein expression by the immortalised human brain endothelial cell line, hCMEC/D3, restricts apical-to-basolateral permeability to rhodamine 123. Tai LM; Reddy PS; Lopez-Ramirez MA; Davies HA; Male DK; Loughlin AJ; Romero IA Brain Res; 2009 Oct; 1292():14-24. PubMed ID: 19631619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]